We are live on ! Find out more
NGNE icon

Neurogene
NGNE

35 hedge funds and large institutions have $186M invested in Neurogene in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,187% more capital invested

Capital invested by funds: $14.4M → $186M (+$171M)

64.32% more ownership

Funds ownership: 10.36% → 74.68% (+64%)

40% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 10

29% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 7

13% more funds holding

Funds holding: 31 → 35 (+4)

Holders
35
Holders Change
+4
Holders Change %
+12.9%
% of All Funds
0.51%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
14
Increased
9
Reduced
7
Closed
10
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
-$10K

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$18.2M
2
SB
Samsara BioCapital
California
+$18.2M
3
GPP
Great Point Partners
Connecticut
+$14.2M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$12.1M
5
RG
Redmile Group
California
+$11.5M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$149K
2
Two Sigma Investments
Two Sigma Investments
New York
-$135K
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$134K
4
Bank of America
Bank of America
North Carolina
-$118K
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$108K
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
26
US Bancorp
Minnesota
$67.2K – – –
UBS Group
27
UBS Group
Switzerland
$19.4K +$13.5K +942 +1,624%
Wells Fargo
28
Wells Fargo
California
$8.02K +$14 +1 +0.2%
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$2K +$1.49K +104 New
Group One Trading
30
Group One Trading
Illinois
$1.43K -$14 -1 -1%
FFA
31
Farther Finance Advisors
California
$969 – – –
TC
32
Truvestments Capital
Florida
$891 – – –
Osaic Holdings
33
Osaic Holdings
Arizona
$485 – – –
JP Morgan Chase
34
JP Morgan Chase
New York
$194 -$14 -1 -9%
National Bank of Canada
35
National Bank of Canada
Quebec, Canada
$158 -$14 -1 -11%
Millennium Management
36
Millennium Management
New York
– -$149K -9,439 Closed
Two Sigma Investments
37
Two Sigma Investments
New York
– -$135K -8,552 Closed
Two Sigma Advisers
38
Two Sigma Advisers
New York
– -$134K -8,470 Closed
Point72 Asset Management
39
Point72 Asset Management
Connecticut
– -$108K -6,834 Closed
State Street
40
State Street
Massachusetts
– -$96.8K -6,128 Closed
KCM
41
Kynam Capital Management
New Jersey
– -$94.9K -6,009 Closed
Citadel Advisors
42
Citadel Advisors
Florida
– -$86.7K -5,490 Closed
Northern Trust
43
Northern Trust
Illinois
– -$54.2K -3,432 Closed
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
– -$52K -3,289 Closed
TRCT
45
Tower Research Capital (TRC)
New York
– -$3.25K -206 Closed
1
2

NGNE Hedge Fund Activity: Q4 2023 in Review

35 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q4 2023, worth a combined $186M — up 1,187% from $14.4M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new NGNE positions and 10 closed out — a net gain of 4 holders — while 9 added to existing stakes and 7 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $18.2M. The largest seller was Millennium Management, exiting entirely with an estimated $149K sold.

  • 35 institutional investors held Neurogene (NGNE) as of Q4 2023, up from 31 in Q3 2023.
  • Funds reported $186M of Neurogene stock for Q4 2023, up 1,187% quarter-over-quarter.
  • 14 funds opened new Neurogene positions in Q4 2023 and 10 closed out, a net change of +4 holders.
  • The largest Neurogene buyer in Q4 2023 was EcoR1 Capital, an estimated $18.2M added.
  • The largest Neurogene seller in Q4 2023 was Millennium Management, an estimated $149K sold.

Based on aggregated 13F filings for Q4 2023.